Defense Threat Reduction Agency (DTRA)
U.S. Department of DefenseBiography
The Defense Threat Reduction Agency (DTRA) is the intellectual, technical and operational leader for the US Department of Defense (DoD) and the U.S. Strategic Command in the effort to combat biological, chemical and nuclear threats.
While the DTRA Chemical and Biological Technologies Directorate (DTRA CB) is not part of Defense Advanced Research Projects Agency (DARPA); it is DARPA’s focal point for chemical and biological scientific and technical expertise. DTRA CB is also “dual-hatted” as the Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD) under the Department of Defense Chemical and Biological Defense Program (CBDP).
DTRA CB serves two key roles in support of DoD CBDP: Funds Manager and Joint Science and Technology Manager. The joint S&T management responsibilities include:
- Development and integration of S&T programs
- Programming, planning, and budgeting documentation for chemical and biological defense S&T programs
- Working with the JPEO-CBD to ensure effective transition of S&T efforts to advanced development
- Participating in Armed Services Biomedical Research Evaluation and Management (ASBRED) Committee meetings to ensure organizational coordination between medical and non-medical S&T liaisons such as DARPA, industry, academia, and other government agencies
- Support for DoD CB Defense S&T international programs
- Management and integration of CB Defense Advanced Concept Technology Demonstrations
DTRA and JSTO-CBD use extramural endeavors such as Broad Agency Announcements to identify, adopt, and adapt emerging and revolutionary sciences that may demonstrate high payoff potential to counter-WMD threats. Companies with applicable novel or revolutionary concepts or products are encouraged to contact DTRA.
The DTRA International Cooperative Biological Engagement Program (CBEP) works to counter threats posed by select agents, related materials, expertise, other emerging infectious disease risks, and to prevent these agents from reaching any state or non-state actors who may use them against the United States or its allies.
The CBEP mission is achieved through Biological Safety & Security capacity building; Disease Surveillance, Detection, Diagnosis, and Reporting; and Cooperative Biological Research. Through these areas CBEP aims to secure dangerous pathogens; promote open and active disease reporting and response; and advance transparent research to understanding pathogens and developing potential countermeasures. CBEP also works with partner countries to improve disease surveillance and response systems.
Notes
Editor’s Picks: Articles and resources related to DTRA. Links may lead to external sites. Read all of CBRNE Central’s DTRA articles.
- DTRA Technical Integrators Return Home From Afghanistan (Jan 2021)
- Tactical Assault Kit Plugins for Decision Support in CBRNE Environments (June 2019)
- Raytheon Awarded Philippines WMD Proliferation Prevention Contract (Apr 2018)
- Numerate, CUBRC Awarded DTRA Contract for ToxTool System (Feb 2018)
- SRC Awarded Contract to Integrate DREAM into the Joint Effects Model (Jan 2018)
- Chimera Secures DTRA WMD A&AS Contract (Jun 2017)
- Leidos Awarded DTRA Weather Prediction Contract (May 2017)
- Virginia Tech to Build Simulation System for CBRN Decision Informatics (Mar 2017)
- New Biosensor Could Help Search for Nuclear Activity (Feb 2017)
- General Dynamics Support to International Nuclear Monitoring System (Jan 2017)
- DoD, DHS Conduct Large Scale Chemical Hazard Modeling Trials (Jan 2017)
- DTRA Threat Working Group Contract Awarded to Apogee-SSU JV (Dec 2016)
- Ebola Vaccine Backed by DTRA Moves Closer to Being Licensed (Oct 2016)
- DoD to Study Omadacycline as Countermeasure for Plague, Anthrax (Oct 2016)
- DTRA/SCC-WMD Hosts the 15th C-WMD Global Synchronization Conference (Sep 2016)
- ‘Second Skin’ Protects Soldiers from Biological, Chemical Agents (Aug 2016)
- The CREATIVE Decontamination System Performance Model (Jul 2016)
- FLIR Awarded DTRA Chemical Decontamination Assurance Contract (Jul 2016)
- DTRA Awards 3.4M Contract for Ebola Countermeasure (Jun 2016)
- DTRA Seeks Proposals for Technical Support Group Services (Mar 2016)
- Coatings to Enhance Chem-Bio Agent Resistance (Mar 2016)
- JIEDDO to JIDA to JIDO: Improvised-Threat Defeat Org Moves to DTRA (Feb 2016)*
- Autonomous Search Capabilities for Radiological-Nuclear Materials (Mar 2016)
- One-Handed Environmental Surface Sampling Device (Mar 2016)
- Nuclear Weapons International Monitoring System Operations (Feb 2016)
- Urban Subsystem CBRN Dispersion Modeling (Jan 2016)
- DTRA Seeks Blue Team Survivability Assessments (Dec 2015)
- In Pictures: DTRA CBD S&T Conference (Jul 2015)
- Adding Chem-Bio Detection to the PackBot (Mar 2015)
- Fundamental Research to Counter Weapons of Mass Destruction (Mar 2015)
- DTRA Creates Nuclear-Focused Directorate (Mar 2015)
- Technologies to Combat Ebola BAA (Jan 2015)
- DoD Threat Reduction Agency Builds Anti-Ebola Capacity (Dec 2014)
- We Have Military Research to Thank for Ebola Vaccines (Nov 2014)
- Micro-Rockets Can Destroy Chemical Weapons (Oct 2014)
- DTRA Awards Contract for Nuclear Treaty Verification Dialogues (Oct 2014)
- Botulinum Neurotoxin Countermeasure Discovery (Oct 2014)
- DTRA Chem-Bio BAA Contract Awards (Oct 2014)
- DTRA Seeks Counter-WMD Research Support Services (Aug 2014)
- BSL 3 Research Laboratory Opens in Kazakhstan (Aug 2014)
- Mapp Biopharmaceutical Award from DTRA for Ebola Drug (Jul 2014)
- Technology Review Shows Past and Future of Biodetection (Jul 2014)
- Cubic Awarded DTRA CBRNE Support Contract (Jul 2014)
- DTRA RFI – Nuclear Test Ban Verification Technologies (Jun 2014)
- Chem-Bio Coatings: More Than Just a Fresh Coat of Paint (Jun 2014)
- DTRA Funds Harvard Development of Biodefense Diagnostics (Mar 2014)
- BAA – New Initiatives for Nuclear Technologies Detection (Mar 2014)
- RFI – Chemical and Biological Agent Blast Environments (Feb 2014)